Skip to main content
. 2024 Nov 25;16(11):e74390. doi: 10.7759/cureus.74390

Figure 1. Distribution of disease subtypes (A) and ANCA subtypes (B) in patients with AAV.

Figure 1

c-ANCA: cytoplasmic-antineutrophil cytoplasmic antibodies, EGPA: eosinophilic granulomatous polyangiitis, GPA: granulomatous polyangiitis, MPA: microscopic polyangiitis, p-ANCA: perinuclear-antineutrophil cytoplasmic antibodies, AAV: ANCA-associated vasculitis